180 288

Cited 131 times in

Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.

Authors
Kim, WH; Matsumoto, K; Bessho, K; Nakamura, T
Citation
The American journal of pathology, 166(4):1017-1028, 2005
Journal Title
The American journal of pathology
ISSN
0002-94401525-2191
Abstract
Liver cirrhosis is characterized by hepatic dysfunction with extensive accumulation of fibrous tissue in the liver. In response to chronic hepatic injury, hepatic portal myofibroblasts and activated hepatic stellate cells (HSCs) play a role in liver fibrosis. Although administration or gene expression of hepatocyte growth factor (HGF) leads to improvement in hepatic fibrosis/cirrhosis, the related mechanisms are not fully understood. We investigated mechanisms involved in resolution from liver cirrhosis by HGF, focusing on growth regulation and apoptosis in portal myofibroblasts. Cultured rat HSCs could not proliferate, were withdrawn after passage, and were replaced by proliferating portal myofibroblasts during the passages. In quiescent HSCs, c-Met receptor expression was undetected whereas c-Met receptor expression was detected in activated HSCs and liver myofibroblasts expressing alpha-smooth muscle actin (alpha-SMA), suggesting that activated HSCs and portal myofibroblasts are targets of HGF. For cultured rat portal myofibroblasts, HGF counteracted phosphorylation of extracellular signal-regulated kinase (Erk) 1/2 and mitogenic stimulus induced by platelet-derived growth factor, induced c-jun N-terminal kinase (JNK) 1 phosphorylation, and promoted apoptotic cell death. In the dimethylnitrosamine rat model of liver cirrhosis, administration of HGF suppressed proliferation while promoting apoptosis of alpha-SMA-positive cells in the liver, events that were associated with reduced hepatic expressions of alpha-SMA and histological resolution from liver cirrhosis. Growth inhibition and enhanced apoptosis in portal myofibroblasts by HGF are newly identified mechanisms aiding resolution from liver fibrosis/cirrhosis by HGF.
MeSH terms
Adipocytes/drug effectsAdipocytes/metabolismAnimalsApoptosis/drug effects*Apoptosis/physiologyBlotting, WesternCell Proliferation/drug effectsCells, CulturedDisease Models, AnimalExtracellular Signal-Regulated MAP Kinases/metabolismFibroblasts/drug effectsFibroblasts/metabolismHepatocyte Growth Factor/metabolismHepatocyte Growth Factor/pharmacology*HumansJNK Mitogen-Activated Protein Kinases/metabolismLiver/drug effects*Liver/metabolismLiver/pathologyLiver Cirrhosis/drug therapy*Liver Cirrhosis/metabolismLiver Cirrhosis/pathologyMAP Kinase Kinase 4MaleMitogen-Activated Protein Kinase Kinases/metabolismProto-Oncogene Proteins c-met/metabolismRatsRats, Sprague-Dawley
DOI
10.1016/S0002-9440(10)62323-1
PMID
15793283
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
AJOU Authors
김, 욱환
Full Text Link
Files in This Item:
1017-1028.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse